Department of Pancreatic Surgery, West China Hospital of Sichuan University, Chengdu, China.
Front Endocrinol (Lausanne). 2022 Jul 22;13:957129. doi: 10.3389/fendo.2022.957129. eCollection 2022.
Diabetes mellitus among patients with exocrine pancreatic disorders is commonly known to be associated with chronic inflammation, including chronic pancreatitis and pancreatic ductal adenocarcinoma (PDAC). The neutrophil-to-lymphocyte ratio (NLR) is a novel marker that indicates the presence of various chronic inflammatory diseases, including type 2 diabetes (T2DM). However, no studies have examined the relationship between the NLR value and diabetes secondary to exocrine pancreatic disorders.
To determine whether the NLR value is associated with diabetes secondary to exocrine pancreatic disorders.
The medical data of subjects with confirmed pancreatic disease who were admitted to the Department of Pancreatic Surgery of our institution from August 2017 to October 2021 were obtained from the database and retrospectively analyzed. Anthropometric measures, laboratory data, including HbA1c, fasting insulin, and fasting C-peptide levels and the inflammatory index (white blood cell count, NLR, platelet-to-lymphocyte ration, monocyte-to-lymphocyte ratio) were recorded. The NLR is the ratio of neutrophils to lymphocytes. A homeostasis model (HOMA-B and HOMA-IR) was used to measure beta-cell dysfunction and insulin resistance.
The NLR values of the diabetes secondary to exocrine pancreatic disorders group were significantly higher than those of the nondiabetic group (P=0.001). In multivariate logistic regression, after adjusting for covariates, high NLR values were found to be an independent risk factor for diabetes secondary to exocrine pancreatic disorders (OR: 1.37, 95% CI: 1.138-1.649, P=0.001). According to Spearman correlation analysis, the NLR was significantly correlated with fasting plasma glucose levels (P<0.0001) and HOMA2-IR values (P=0.02).
The NLR inflammation marker was significantly higher in subjects with diabetes secondary to exocrine pancreatic disorders and was associated with insulin resistance. NLR values may be reliable predictive markers for diabetes among patients with exocrine pancreatic disorders.
患有胰腺外分泌疾病的患者中,糖尿病通常与慢性炎症有关,包括慢性胰腺炎和胰腺导管腺癌(PDAC)。中性粒细胞与淋巴细胞比值(NLR)是一种新型标志物,可提示存在各种慢性炎症性疾病,包括 2 型糖尿病(T2DM)。然而,尚无研究探讨 NLR 值与胰腺外分泌疾病继发糖尿病之间的关系。
确定 NLR 值是否与胰腺外分泌疾病继发糖尿病相关。
从我院胰腺外科 2017 年 8 月至 2021 年 10 月收治的经确诊的胰腺疾病患者数据库中获取研究对象的医学数据,并进行回顾性分析。记录人体测量学指标、实验室数据,包括糖化血红蛋白(HbA1c)、空腹胰岛素和空腹 C 肽水平以及炎症指标(白细胞计数、NLR、血小板与淋巴细胞比值、单核细胞与淋巴细胞比值)。NLR 是中性粒细胞与淋巴细胞的比值。采用稳态模型(HOMA-B 和 HOMA-IR)来评估胰岛β细胞功能障碍和胰岛素抵抗情况。
胰腺外分泌疾病继发糖尿病组的 NLR 值明显高于非糖尿病组(P=0.001)。多变量逻辑回归分析显示,在校正了混杂因素后,高 NLR 值是胰腺外分泌疾病继发糖尿病的独立危险因素(OR:1.37,95%CI:1.138-1.649,P=0.001)。Spearman 相关分析显示,NLR 与空腹血糖水平(P<0.0001)和 HOMA2-IR 值(P=0.02)显著相关。
胰腺外分泌疾病继发糖尿病患者的 NLR 炎症标志物明显升高,与胰岛素抵抗相关。NLR 值可能是胰腺外分泌疾病患者发生糖尿病的可靠预测标志物。